Skip to main content
Log in

Simultaneous dobutamine stress echocardiography and dobutamine scintigraphy (99mTc-MIBI-SPET) for assessment of coronary artery disease

  • Articles
  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Abstract

Background: Simultaneous dobutamine stress echocardiography (DSE) and99mTc-MIBI-SPET (DMS) for the evaluation of the presence and the extent of coronary artery disease (CAD) were assessed for a head to head comparison regarding the diagnostic accuracy of the two tests.

Methods and Results: Forty-five consecutive patients (33 males and 12 females: 53±6.8 yr.) underwent exercise electrocardiography and simultaneous dobutamine stress echocardiography and MIBI-SPET imaging. Coronary angiography was performed in all patients (significant coronary stenosis > 50%). On the basis of the results of exercise electrocardiogram the pre-test probability for coronary artery disease (Diamond's algorithm) was low (45.6±12.7 %). The overall specificity, sensitivity and predictive accuracy of Echo-dobutamine stress test for diagnosis of the presence or absence of CAD were: specificity 82%, sensitivity 76%, diagnostic accuracy 80%, positive predictive value 90%, negative predictive value 40%. The overall specificity, sensitivity and predictive accuracy of MIBI-SPET-dobutamine test for diagnosis of the presence or absence of CAD were: specificity 86%, sensitivity 87%, diagnostic accuracy 84%, positive predictive value 97%, negative predictive value 54%. MIBI-SPET-dobutamine test showed a significantly higher sensitivity in comparison with ECHO-dobutamine test (P<0.05).

Conclusion: Both noninvasive methods for the detection of CAD showed a good diagnostic accuracy. Nevertheless the SPET model showed an higher sensitivity in comparison with DSE model, essentially in the presence of a lower extent of CAD and during submaximal test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Picano E. Stress echocardiography. From pathophysiological toy to diagnostic tool. Circulation 1992; 85: 1604–12.

    PubMed  Google Scholar 

  2. Salustri A, Fioretti PM, Pozzoli MMA, McNeil AJ, Roelandt JRTC. Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease. Eur Heart J: 1992; 13: 70–7.

    Google Scholar 

  3. Mason JR, Palc RT, Freeman ML, Virupannavar S, Loeb HS, Kaplan E, Gunnar RM; Thallium scintigraphy during dobutamine infusion: non exercise-dependent screening test for coronary disease. Am Heart J 1984; 107: 481–85.

    PubMed  Google Scholar 

  4. Pennell DJ, Underwood DSR, Swanton RH, Walker JM, Ell PJ. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991; 18: 1471–9.

    PubMed  Google Scholar 

  5. McGillem MJ, DeBoe SF, Friedman HZ, Mancini GBJ. The effect of dopamine and dobutamine on regional function in presence of rigid coronary stenoses and subcritical impairments of reactive hyperaemia. Am Heart J 1988; 115: 970–7.

    PubMed  Google Scholar 

  6. Tuttle RR, Pollock GD, Todd G, MacDonald B, Tust R, Dusenberry W: The effect of dobutamine on cardiac oxygen balance, regional blood flow and infarction severity after coronary artery narrowing in dogs. Circ Res 1977; 41: 357–64.

    PubMed  Google Scholar 

  7. Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of exercise testing and interpretations. Philadelphia. Lea & Febiger, 1987.

    Google Scholar 

  8. Fung AY, Gallegher KP, Buda AJ. The physiologic basis of dobutamine as compared with dipyridamole stress intervention in the assessment of critical coronary stenoses. Circulation 1987; 76: 943–51.

    PubMed  Google Scholar 

  9. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979; 300: 1350–8.

    PubMed  Google Scholar 

  10. Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H. Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992; 19: 197–202.

    PubMed  Google Scholar 

  11. Schiller NB, Shan PM, Crawford M, et al. American Society of Echocardiography Committee on standards subcommittee on quantitation of two dimensional echocardiograms: Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echo 1989; 2: 358–67.

    PubMed  Google Scholar 

  12. Berman DS, Kiat H, Train KV, Garcia E, Friedman J, Maddahi J. Technetium 99m Sestamibi in the assessment of chronic artery disease. Semin Nucl Med 1991; 21: 190–212.

    PubMed  Google Scholar 

  13. Judkins MP Selective coronary arteriography, a percutaneous transfemoral technic. Radiology 1967; 89: 815–23.

    PubMed  Google Scholar 

  14. Mertens H, Sawada SG, Ryan T at al. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography. Circulation 1993; 88: 15–9.

    PubMed  Google Scholar 

  15. Sawada SG, Segar DS, Ryan T et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605–14.

    PubMed  Google Scholar 

  16. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991; 67: 1311–8.

    PubMed  Google Scholar 

  17. Mazeika PK, Nazadin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992; 19: 1203–11.

    PubMed  Google Scholar 

  18. Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy or both? J Am Coll Cardiol 1993; 22: 159–67.

    PubMed  Google Scholar 

  19. Marwick T, Willemart B, D'Hondt AM et al. Selection of the optimal non exercise stress test for the evaluation of ischemic regional myocardial dysfunction and malperfusion: comparison of dobutamine and adenosine using echocardiography and Tc 99mMIBI single photon emission computed tomography. Circulation 1993; 87: 345–54.

    PubMed  Google Scholar 

  20. Mairesse GH, Marwick TH, Vanoverschelde JJ, Baudhuin T, Wijns W, Melin JA, Detry JR. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease. Comparison with two-dimensional echocardiography and technetium - 99m MIBI perfusion scintigraphy. J Am Coll Cardiol 1994; 24: 920–7.

    PubMed  Google Scholar 

  21. Salustri A, Fioretti PM, Pozzoli MMA, McNeill AJ, Roelandt JRTC. Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease. EHJ 1992; 13, 70–77.

    Google Scholar 

  22. Pozzoli MMA, Fioretti PM, Salustri A, Reijs AEM, Roelandt JRTC. Exercise echocardiography and technetium-99m-MIBI SPECT in the detection of coronary artery disease. AM J Cardiol 1991; 67: 350–55.

    PubMed  Google Scholar 

  23. Di Bello V, Bellina CR, Gori E, Molea N, Talarico L, Boni G, Magagnini E, Matteucci F, Giorgi D, Lazzeri E, Bertini A, Romano MF, Bianchi R, Giusti C. Incremental diagnostic value of Dobutamine stress echocardiography and dobutamine scintigraphy (99mTc- MIBI-SPET) for assessment of presence and extent of coronary artery disease. Journal of Nuclear Cardiology; in press.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Di Bello, V., Riccardo Bellina, C., Molea, N. et al. Simultaneous dobutamine stress echocardiography and dobutamine scintigraphy (99mTc-MIBI-SPET) for assessment of coronary artery disease. Int J Cardiac Imag 12, 185–190 (1996). https://doi.org/10.1007/BF01806221

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806221

Key words

Navigation